Japan Approves First Humira Biosimilar

Mylan Will Market Fujifilm Kyowa Kirin’s Adalimumab Rival In Japan

 
• By David Wallace
  
Thumbs_Up_Japan
Japan has given the nod to its first adalimumab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products